4-Amino-3-Chlorophenol CAS 17609-80-2 Lenvatinib Mesylate Intermediate Purity>99.0% (HPLC)
Ruifu Chemical Supply Lenvatinib Mesylate Intermediates Ndi Kuyera Kwambiri
Lenvatinib Mesylate CAS 857890-39-2
4-Chloro-7-Methoxyquinoline-6-Carboxamide CAS 417721-36-9
Desquinolinyl Lenvatinib;1-(2-Chloro-4-Hydroxyphenyl)-3-Cyclopropylurea CAS 796848-79-8
Methyl 7-Methoxy-4-Oxo-1,4-Dihydroquinoline-6-Carboxylate CAS 205448-65-3
Methyl 4-Amino-2-Methoxybenzoate CAS 27492-84-8
5-(Methoxymethylene) -2,2-Dimethyl-1,3-Dioxane-4,6-Dione CAS 15568-85-1
4-Amino-3-Chlorophenol CAS 17609-80-2
4-Amino-3-Chlorophenol Hydrochloride CAS 52671-64-4
Methyl 4-Chloro-7-Methoxyquinoline-6-Carboxylate CAS 205448-66-4
Dzina la Chemical | 4-Amino-3-Chlorophenol |
Mawu ofanana ndi mawu | 3-Chloro-4-Aminophenol;Lenvaint-G |
Nambala ya CAS | 17609-80-2 |
Nambala ya CAT | RF-PI1968 |
Stock Status | Mu Stock, Kupanga Kukula Mpaka Matani |
Molecular Formula | C6H6ClNO |
Kulemera kwa Maselo | 143.57 |
Kuchulukana | 1.406±0.060 g/cm3 |
Mtundu | Ruifu Chemical |
Kanthu | Zofotokozera |
Maonekedwe | Brown Solid Powder |
1 H NMR Spectrum | Zogwirizana ndi Kapangidwe |
Chizindikiritso-HPLC | Kusunga nthawi yofanana ndi muyezo |
Kuyera / Kusanthula Njira | >99.0% (HPLC) |
Melting Point | 138.0 ~ 141.0 ℃ |
Kutaya pa Kuyanika | <1.00% |
Zotsalira pa Ignition | <0.30% |
Zonse Zonyansa | <1.00% |
Test Standard | Enterprise Standard |
Kugwiritsa ntchito | Pakati pa Lenvatinib Mesylate (CAS: 857890-39-2) |
Phukusi: Botolo, Aluminiyamu zojambulazo thumba, 25kg/Cardboard Drum, kapena malinga ndi lamulo la kasitomala
Mkhalidwe Wosungira:Sungani muzitsulo zosindikizidwa pamalo ozizira ndi owuma;Tetezani ku kuwala ndi chinyezi
4-Amino-3-Chlorophenol (CAS: 17609-80-2) ndi mankhwala ofunikira kwambiri apakati, omwe amagwiritsidwa ntchito kwambiri popanga ndi kaphatikizidwe ka anti-chotupa, matenda a mtima, matenda a ubongo.4-Amino-3-Chlorophenol ndizofunikira zapakatikati pokonzekera Lenvatinib Mesylate (CAS: 857890-39-2).Yopangidwa ndi Eisai Inc., lenvatinib mesylate ndi vascular endothelial growth factor receptor (VEGF) inhibitor yomwe imakhala ndi zochita zotsutsana ndi VEGF subtypes 1, 2, ndi 3 ndipo idavomerezedwa ndi FDA mu 2015 kuchiza khansa ya chithokomiro yosiyana yomwe imapezeka kwanuko. mobwerezabwereza, metastatic, kapena kupita patsogolo ndipo sanayankhe chithandizo cha radioactive ayodini.Mu Meyi 2016, a FDA adavomereza mankhwalawa ngati mankhwala ophatikizika ndi everolimus pochiza matenda a renal cell carcinoma.Chifukwa chakuti VEGF (ndi fibroblast growth factor receptors, yotchedwa FGFRs) imaganiziridwa kuti imakhala ndi gawo la njira zowonetsera mtima, VEGF2R ndi FGFR zoletsa zimaganiziridwa kuti ndizo njira zomwe zimayambitsa zotsatira za lenvatinib mesylate, zomwe ndi matenda oopsa.